Research and Markets (http://www.researchandmarkets.com/research/h767h8/global_epinephrine)
has announced the addition of the "Global
Epinephrine Market 2011-2015" report to their offering.
TechNavio's analysts forecast the Global Epinephrine market to grow at a
CAGR of 11.6 percent over the period 2011-2015. One of the key factors
contributing to this market growth is the increasing prevalence of
allergies. The Global Epinephrine market has also been witnessing the
development of CFC-free epinephrine inhalers. However, the shortage of
drug supply to meet demand could pose a challenge to the growth of this
Key vendors dominating this market space include Mylan Inc., ALK Abello
A/S, Shionogi Inc., and Lincoln Medical Ltd.
Commenting on the report, an analyst from TechNavio's Healthcare team
said; Improper administration of epinephrine injections can cause side
effects such as chest pain, irregular heartbeat, loss of consciousness,
and blistering of skin. In order to address these drawbacks, vendors are
introducing auto-injecting devices that dispense epinephrine injections.
Epinephrine drug manufacturers are providing a wide range of
auto-injectors, which provide accuracy and safety while using
According to the report, the increase in the number of people who have
developed allergies to food items, food additives, pollens, latex, dust,
etc., has led to an increase in the number of patients suffering from
anaphylactic shock, which is one of the major health concerns globally.
Since epinephrine drugs provide effective treatment for anaphylactic
shock during an emergency, the use of such drugs has been on the rise,
thereby contributing to the growth of the Global Epinephrine market.
For more information visit http://www.researchandmarkets.com/research/h767h8/global_epinephrine